We did it! $2M for type 1 diabetes research
This year, we asked you a question: could you be the 1?
Could you be the 1 who…
- Helps change the lives of more than 125,000 Australians?
- Makes an investment in a future without T1D, one which pays life-changing dividends?
- Moves the needle in 2021?
And you answered the call. Thank you for coming together as 1 community to bring about this incredible achievement! Your generous contribution is a critical part of our mission to improve lives and cure T1D. It’s now working twice as hard to support cutting-edge T1D research.
Our collective achievement is made even more powerful on the 100th anniversary of the discovery of insulin this year. Because of you, we can continue to support the most promising, cutting-edge Australian research so that we don’t need to wait another 100 years for the next big breakthrough.
But don’t just take it from us – these researchers want to say thanks too.
Thank you for doubling your impact today. It was 1 gift which will keep on giving until you can say: “I’m the 1 who created a world without type 1 diabetes.”
Mike Wilson OAM
CEO & Managing Director, JDRF Australia
JDRF welcomes TGA approval on Pfizer vaccine for children aged 12-15
JDRF Australia welcomes the announcement that the Therapeutic Goods Administration (TGA) has approved the Pfizer COVID-19 vaccine for children aged 12-15. We look forward to the final decision from the Australian Technical Advisory Group on Immunisation (ATAGI) to prioritise children with underlying conditions, including type 1 diabetes, and include them immediately in the vaccine rollout. […]
JDRF welcomes leading medical researcher to Board to support continued research excellence
JDRF Australia are delighted to welcome Professor Fabienne Mackay to the Board of JDRF Australia. Professor Mackay, who joined the Board at the June 2021 Board meeting, will also play an important role on JDRF’s Board Research Committee, evaluating and ensuring JDRF continues to support the best local research into type 1 diabetes (T1D). Prof. Mackay obtained her PhD from Louis Pasteur University in Strasbourg, France and has more than […]
New Science Accelerator Grants Awarded to Early-Mid Career Researchers
JDRF and The Leona M. and Harry B. Helmsley Charitable Trust are excited to announce more than $1.2 million in new funding for three outstanding early-mid career Australian researchers. The ENDIA Early-Mid Career Science Accelerator Awards will support the researchers in carrying out new projects using samples collected as part of the ENDIA study, the […]
T1D Research Roundup: June 2021
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. This month, the American Diabetes Association held their 81st Scientific Sessions. The world’s top type 1 […]